HELPING THE OTHERS REALIZE THE ADVANTAGES OF POLYCYSTIC OVARY SYNDROME

DPP4 inhibitors lower the degradation of incretins, hence expanding glucose-dependent insulin release. In people with type two diabetes, They can be regarded as weight neutral. New data recommend that in obese Women of all ages with PCOS, DPP4 inhibitors have beneficial effects on weight loss and lessen blood glucose degrees.Endocrine Society Recom